FIELD: medicine.
SUBSTANCE: use of a nanoparticle or an aggregate of nanoparticles and a composition based on them for improvement of training, memorizing, and attention in a subject is disclosed, where material of the nanoparticle or the aggregate of nanoparticles is selected from conductive material selected from Tl, Po, Ag, Pd, Ir, Pt, and/or Au, and organic material having adjacent sp2-hybridized carbon centers in its structure, and insulation material selected from La2O3, SiO2, SnO2, Ta2O5, ReO2, ZrO2, HfO2, Y2O3, and diamond-like carbon, where i) a median size of a core of the nanoparticle or the aggregate of nanoparticles of a population is at least 30 nm, when material is conductive material, where ii) the core of the nanoparticle or the aggregate of nanoparticles is covered with biocompatible coating providing a negative surface charge, where iii) nanoparticles or aggregates of nanoparticles are not used as a carrier of a therapeutic compound or a drug, and where iv) biocompatible coating providing the negative surface charge is selected from phosphate, dicarboxylic acid, succinic acid, or sulphate. The use of the above-described nanoparticles or the aggregate of nanoparticles and the composition based on them for the treatment of at least one symptom of pathological stress is also disclosed.
EFFECT: group of inventions provides treatment of diseases and improvement of conditions without impact on a nanoparticle or an aggregate of nanoparticles of an electric field or any other external activation source.
7 cl, 5 dwg, 3 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
NANOPARTICLES FOR USE FOR TREATMENT OF NEUROLOGICAL DISORDER | 2018 |
|
RU2779758C2 |
RESTORATION OF THE SENSORIMOTOR FUNCTION USING A NEUROPROSTHETIC SYSTEM AND METHOD FOR IMPLEMENTATION THEREOF | 2020 |
|
RU2772637C2 |
USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) | 2017 |
|
RU2742828C2 |
PEPTIDE CONJUGATED PARTICLES | 2014 |
|
RU2685186C2 |
FERRITIN NANOPARTICLES CONTAINING CHEMOTHERAPEUTIC AGENT | 2019 |
|
RU2810594C2 |
PRODUCTION OF GABA-ergic NEURONS in vitro OF EMBRYO STEM CELLS AND APPLICATION THEREOF IN TREATING NEURAL DISORDERS | 2004 |
|
RU2380410C2 |
STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS, COMPOSITIONS THEREOF AND METHODS OF PRODUCING SAID MESENCHYMAL AND NEURONAL MARKERS | 2017 |
|
RU2741839C2 |
METHYLTHIONINIUM FOR TREATING SYNAPTOPATHIES | 2020 |
|
RU2835868C2 |
NON-MEDUCATIONAL METHOD OF TREATMENT OF ADYNAMIC DEPRESSIONS | 2022 |
|
RU2801161C1 |
METHODS AND COMPOSITIONS FOR STABLE IMMUNOTHERAPY | 2014 |
|
RU2696876C2 |
Authors
Dates
2022-10-26—Published
2018-12-18—Filed